Enhanced Disinfection for Hospital Room Contamination
Trial Summary
What is the purpose of this trial?
The purpose of this study is to determine if enhanced daily application of disinfectant with persistent 24-hour activity decreases the environmental bioburden compared to standard practice.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Sani-24 Surface Disinfectant Cleaner Germicidal?
Research shows that cleaning and disinfection products can significantly reduce bacteria on surfaces, which helps prevent the spread of infections in hospitals. Although not directly about Sani-24, studies on similar disinfectants indicate they are effective in reducing harmful bacteria and improving hygiene in healthcare settings.12345
Is the enhanced disinfection treatment generally safe for humans?
How is the treatment Sani24 different from other disinfection methods?
Research Team
Deverick Anderson, MD
Principal Investigator
Duke University
Eligibility Criteria
This trial is for adult patients in the hospital who are on contact precautions for any reason or have a positive culture for certain infections upon room admission. They must have spent at least one night in their room and expect to stay another 48 hours.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Application of disinfectants and measurement of room contamination over 4 days
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Sani24
- Standard EPA-registered disinfectant
Sani24 is already approved in United States for the following indications:
- Environmental disinfection in hospital rooms
- Control of HAI-causing microorganisms
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor
University of North Carolina
Collaborator